Additionally, mutations in NNT, encoding the mitochondrial antioxidant nicotinamide nucleotide transhydrogenase, account for 10% of cases in our FGD cohort (5). The gene discussed is NNT; the disease is Aarskog-Scott syndrome, X-linked.